Julia Yue Cui Selected Research

Xenobiotics

2/2022	Understanding the physiological functions of the host xenobiotic-sensing nuclear receptors PXR and CAR on the gut microbiome using genetically modified mice.
12/2021	Cadmium exposure modulates the gut-liver axis in an Alzheimer's disease mouse model.
11/2021	Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature.
1/2020	Gut Microbiome Critically Impacts PCB-induced Changes in Metabolic Fingerprints and the Hepatic Transcriptome in Mice.
11/2018	Coordinate regulation of long non-coding RNAs and protein-coding genes in germ-free mice.
1/2018	Regulation of protein-coding gene and long noncoding RNA pairs in liver of conventional and germ-free mice following oral PBDE exposure.
6/2017	Remote Sensing between Liver and Intestine: Importance of Microbial Metabolites.
1/2016	RNA Sequencing Quantification of Xenobiotic-Processing Genes in Various Sections of the Intestine in Comparison to the Liver of Male Mice.
1/2016	RNA-Seq reveals common and unique PXR- and CAR-target gene signatures in the mouse liver transcriptome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julia Yue Cui Research Topics

Disease

9	Inflammation (Inflammations) 02/2022 - 01/2016
4	Dysbiosis 10/2021 - 01/2018
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2017
3	Obesity 11/2021 - 06/2017
2	Liver Neoplasms (Liver Cancer) 01/2022 - 10/2021
2	Carcinogenesis 01/2022 - 05/2011
2	Non-alcoholic Fatty Liver Disease 01/2022 - 11/2021
2	Neoplasms (Cancer) 10/2021 - 01/2017
2	Breast Neoplasms (Breast Cancer) 06/2012 - 01/2012
1	Fatty Liver 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Disease Susceptibility (Diathesis) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Noise-Induced Hearing Loss (Acoustic Trauma) 01/2018
1	Infections 01/2018
1	Parasitic Diseases (Parasitic Disease) 01/2018
1	Malnutrition (Nutritional Deficiencies) 06/2017
1	Asthma (Bronchial Asthma) 06/2017
1	Nervous System Diseases (Neurological Disorders) 06/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Drug-Related Side Effects and Adverse Reactions 02/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2016
1	Acute-Phase Reaction 01/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2016

Drug/Important Bio-Agent (IBA)

9	XenobioticsIBA 02/2022 - 01/2016
4	Pharmaceutical PreparationsIBA 02/2022 - 02/2016
3	Bile Acids and Salts (Bile Acids)IBA 02/2022 - 01/2017
3	Pregnane X ReceptorIBA 02/2022 - 01/2020
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2022 - 05/2011
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2018
2	Halogenated Diphenyl EthersIBA 01/2019 - 01/2018
2	pentabromodiphenyl ether (PBDE)IBA 01/2019 - 01/2018
2	EnzymesIBA 01/2018 - 02/2016
2	Proteins (Proteins, Gene)FDA Link 06/2012 - 01/2012
1	Constitutive Androstane ReceptorIBA 02/2022
1	choloylglycine hydrolaseIBA 02/2022
1	Taurine FDA Link 02/2022
1	Dietary CholesterolIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	CarcinogensIBA 01/2022
1	CholesterolIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	CadmiumIBA 12/2021
1	Apolipoprotein E4IBA 12/2021
1	2,2',4,4',5-brominated diphenyl etherIBA 10/2021
1	quinone (benzoquinone)IBA 01/2021
1	NAD (NADH)IBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	LeptinIBA 01/2020
1	Polychlorinated Biphenyls (PCBs)IBA 01/2020
1	Dietary Fats (Dietary Fat)IBA 01/2020
1	CytokinesIBA 01/2020
1	3-(indol-3-yl)propionic acidIBA 01/2019
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 01/2019
1	Tryptophan (L-Tryptophan)FDA Link 01/2019
1	Long Noncoding RNAIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	LipidsIBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	1,4- bis(2- (3,5- dichloropyridyloxy))benzeneIBA 01/2016
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	IronIBA 01/2016
1	Pregnenolone Carbonitrile (PCN)IBA 01/2016
1	RetinoidsIBA 01/2016
1	Equilibrative Nucleoside Transporter 1IBA 06/2012
1	Adenosine Triphosphate (ATP)IBA 01/2012
1	Multidrug Resistance-Associated ProteinsIBA 01/2012

Therapy/Procedure

1	Caloric Restriction 01/2020